Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Andreoli

Showing results (121-130 of 221) with videos related to

Pageof 23
Sort By:
Annals of the Rheumatic Diseases|October 26, 2010
Anti-β₂-glycoprotein I IgG antibodies from 1-year-old healthy children born to mothers with systemic autoimmune diseases preferentially target domain 4/5: might it be the reason for their 'innocent' profile?Laura Andreoli, Cecilia Nalli, Mario Motta, et al.
Journal of Immunology Research|July 18, 2015
The Pathogenicity of Anti-β2GP1-IgG Autoantibodies Depends on Fc GlycosylationChristoph Fickentscher, Iryna Magorivska, Christina Janko, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|May 6, 2015
Clinical characterization of antiphospholipid syndrome by detection of IgG antibodies against β2 -glycoprotein i domain 1 and domain 4/5: ratio of anti-domain 1 to anti-domain 4/5 as a useful new biomarker for antiphospholipid syndromeLaura Andreoli, Cecilia B Chighizola, Cecilia Nalli, et al.
Arthritis Care & Research|July 9, 2016
Effects of Belimumab on Flare Rate and Expected Damage Progression in Patients With Active Systemic Lupus ErythematosusLuca Iaccarino, Silvano Bettio, Rossella Reggia, et al.
Clinical Reviews in Allergy & Immunology|January 18, 2022
Reproductive Issues and Pregnancy Implications in Systemic SclerosisMaria-Grazia Lazzaroni, Francesca Crisafulli, Liala Moschetti, et al.
Lupus Science & Medicine|October 17, 2023
COVID-19 prognosis in systemic lupus erythematosus compared with rheumatoid arthritis and spondyloarthritis: results from the CONTROL-19 Study by the Italian Society for RheumatologyChiara Scirocco, Sara Ferrigno, Laura Andreoli, et al.
Frontiers in Pharmacology|April 5, 2021
The Influence of Treatment of Inflammatory Arthritis During Pregnancy on the Long-Term Children's OutcomeCecilia Nalli, Jessica Galli, Daniele Lini, et al.
Clinical and Experimental Rheumatology|March 29, 2022
Gender differences in primary antiphospholipid syndrome with vascular manifestations in 433 patients from four European centresLiala Moschetti, Luisa Dal Pozzolo, Veronique Le Guern, et al.
Journal of the Academy of Consultation-Liaison Psychiatry|May 21, 2025
Hallucinations and related perceptual phenomena in systemic lupus erythematosus and inflammatory arthritis: a cross-sectional mixed methods studyArjoon Arunasalam, Thomas A Pollak, Avni Varshney, et al.
Frontiers in Immunology|October 3, 2022
Frequency of positive antiphospholipid antibodies in pregnant women with SARS-CoV-2 infection and impact on pregnancy outcome: A single-center prospective study on 151 pregnanciesGiorgia Ingrid Gozzoli, Elda Piovani, Beatrice Negri, et al.
Pageof 23

Showing results (121-130 of 221) with videos related to

Sort By:
Pageof 23
Annals of the Rheumatic Diseases|October 26, 2010
Anti-β₂-glycoprotein I IgG antibodies from 1-year-old healthy children born to mothers with systemic autoimmune diseases preferentially target domain 4/5: might it be the reason for their 'innocent' profile?Laura Andreoli, Cecilia Nalli, Mario Motta, et al.
Journal of Immunology Research|July 18, 2015
The Pathogenicity of Anti-β2GP1-IgG Autoantibodies Depends on Fc GlycosylationChristoph Fickentscher, Iryna Magorivska, Christina Janko, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|May 6, 2015
Clinical characterization of antiphospholipid syndrome by detection of IgG antibodies against β2 -glycoprotein i domain 1 and domain 4/5: ratio of anti-domain 1 to anti-domain 4/5 as a useful new biomarker for antiphospholipid syndromeLaura Andreoli, Cecilia B Chighizola, Cecilia Nalli, et al.
Arthritis Care & Research|July 9, 2016
Effects of Belimumab on Flare Rate and Expected Damage Progression in Patients With Active Systemic Lupus ErythematosusLuca Iaccarino, Silvano Bettio, Rossella Reggia, et al.
Clinical Reviews in Allergy & Immunology|January 18, 2022
Reproductive Issues and Pregnancy Implications in Systemic SclerosisMaria-Grazia Lazzaroni, Francesca Crisafulli, Liala Moschetti, et al.
Lupus Science & Medicine|October 17, 2023
COVID-19 prognosis in systemic lupus erythematosus compared with rheumatoid arthritis and spondyloarthritis: results from the CONTROL-19 Study by the Italian Society for RheumatologyChiara Scirocco, Sara Ferrigno, Laura Andreoli, et al.
Frontiers in Pharmacology|April 5, 2021
The Influence of Treatment of Inflammatory Arthritis During Pregnancy on the Long-Term Children's OutcomeCecilia Nalli, Jessica Galli, Daniele Lini, et al.
Clinical and Experimental Rheumatology|March 29, 2022
Gender differences in primary antiphospholipid syndrome with vascular manifestations in 433 patients from four European centresLiala Moschetti, Luisa Dal Pozzolo, Veronique Le Guern, et al.
Journal of the Academy of Consultation-Liaison Psychiatry|May 21, 2025
Hallucinations and related perceptual phenomena in systemic lupus erythematosus and inflammatory arthritis: a cross-sectional mixed methods studyArjoon Arunasalam, Thomas A Pollak, Avni Varshney, et al.
Frontiers in Immunology|October 3, 2022
Frequency of positive antiphospholipid antibodies in pregnant women with SARS-CoV-2 infection and impact on pregnancy outcome: A single-center prospective study on 151 pregnanciesGiorgia Ingrid Gozzoli, Elda Piovani, Beatrice Negri, et al.
Pageof 23